About this Course
This course focuses on the early stages of drug discovery and the identification of promising compounds with which to begin the hunt for a novel drug. Different types of assays and methods are reviewed that are used to screen libraries of molecules in the preliminary search for compounds with activity. Methods are discussed for validating that active molecules are indeed engaging a target associated with a predicted therapeutic benefit. Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended
What You'll Learn
- Understand screening methods for molecule libraries
- Identify types of assays used in early drug discovery
- Validate active molecules targeting therapeutic effects
Prerequisites
- Advanced coursework or working knowledge in biological sciences and organic chemistry recommended
Instructors
Erland Stevens, PhD
James G. Martin Professor of Chemistry, Davidson College
W. Ross Tracey, PhD
Associate Director, Biomedical Research Learning, Novartis
Douglas S. Auld, PhD
Associate Director, Discovery Sciences, Biomedical Research, Novartis
Alan P. Brown, PhD, DABT
Director, Preclinical Safety, Biomedical Research, Novartis